Your application for a Courtesy Membership is under review

We have just received your information and we will get back to you shortly. Check out the steps below:

Information sent

2

Application in analysis

3

Feedback email

4

Complimentary access activated

* Required fields
* I confirm that I have read and agree to the Terms and Conditions of GRI Club

Next Steps

1

Our Approval Council will review your application

2

Upon approval, you'll receive a welcome email

3

Log in to activate your Complimentary Online Access

Xavier Marceau
Xavier Marceau
VP - Head of Global Real Estate & Facilities, Ipsen

Introduction by GRI

Send a brief message to your Account Manager, who will be happy to assist you
Sucessful Registration! Our team will reach out soon to proceed with the next steps.
Send
Your Introduction Request was successfully sent.
Soon your Account Manager will get back to you regarding this request.

Schedule a Meeting

Please propose 2 slots that are convenient for you. Feel free to add a short comment to make the connection easier
Sucessful Registration! Our team will reach out soon to proceed with the next steps.
America/Adak (GMT -10:00)
Send
Your Private Meeting suggestion was successfully sent.
You'll receive an email with the confirmation.
Biography
Global Real Estate leader for more than 25 years, Xavier has a solid international experience in Real Estate and Construction matters, on most of the asset types.
He is an executive specialized in footprint optimization, workplace strategy, major projects delivery, climate impact investment.

Xavier is convinced that generalized hybridization is a fantastic opportunity to generate intergenerational solidarity and sustainable developments for all kinds of organization, and that there is an urgent need to further improve buildings' energy performance, while changing the way they are used and making progress on global recycling.
In that purpose, CRE strategy must reflect the ambition of the organization and bring an increased drive on it.
Ipsen
Ipsen’s vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience.
www.ipsen.com
←  SHARE